02 Dec 2022
Research, published in JCI Insight, indicates that oestrogen receptor-positive breast cancer that has become endocrine resistant may be successfully treated by a new class of drugs currently undergoing clinical trials.
Endocrine-disrupting chemical levels found at alarming levels in Australia
11 Apr 2024
Risk of depression during menopause transition not universal
11 Apr 2024
Patients with long Covid continue to show inflammatory proteins in blood
11 Apr 2024
People with obesity and high weight linked to feeling increased pain intensity
11 Apr 2024